Trials / Conditions / Salivary Cancer
Salivary Cancer
3 registered clinical trials studyying Salivary Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers NCT02749903 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Active Not Recruiting | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) NCT02628067 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentri NCT02091141 | Genentech, Inc. | Phase 2 |